Biodesix Net Income vs. Number Of Shares Shorted

BDSX Stock  USD 0.82  0.01  1.05%   
Based on the key profitability measurements obtained from Biodesix's financial statements, Biodesix may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Biodesix's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2017-12-31
Previous Quarter
-10.8 M
Current Value
-10.3 M
Quarterly Volatility
4.7 M
 
Covid
At this time, Biodesix's Days Sales Outstanding is fairly stable compared to the past year. Days Of Sales Outstanding is likely to rise to 66.92 in 2025, whereas Price To Sales Ratio is likely to drop 3.36 in 2025. At this time, Biodesix's Interest Income is fairly stable compared to the past year. Change To Netincome is likely to rise to about 22.9 M in 2025, whereas Net Interest Income is likely to drop (9.2 M) in 2025.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.70.85
Significantly Down
Slightly volatile
For Biodesix profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biodesix to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biodesix utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biodesix's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biodesix over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biodesix. If investors know Biodesix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biodesix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.38)
Revenue Per Share
0.566
Quarterly Revenue Growth
0.345
Return On Assets
(0.23)
Return On Equity
(3.32)
The market value of Biodesix is measured differently than its book value, which is the value of Biodesix that is recorded on the company's balance sheet. Investors also form their own opinion of Biodesix's value that differs from its market value or its book value, called intrinsic value, which is Biodesix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biodesix's market value can be influenced by many factors that don't directly affect Biodesix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biodesix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biodesix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biodesix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biodesix Number Of Shares Shorted vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Biodesix's current stock value. Our valuation model uses many indicators to compare Biodesix value to that of its competitors to determine the firm's financial worth.
Biodesix is rated below average in net income category among its peers. It is rated below average in number of shares shorted category among its peers . Biodesix reported Net Loss of (46.93 Million) in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biodesix's earnings, one of the primary drivers of an investment's value.

Biodesix Number Of Shares Shorted vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Biodesix

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(52.15 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Biodesix

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
748.37 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Biodesix Number Of Shares Shorted Comparison

Biodesix is currently under evaluation in number of shares shorted category among its peers.

Biodesix Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Biodesix, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biodesix will eventually generate negative long term returns. The profitability progress is the general direction of Biodesix's change in net profit over the period of time. It can combine multiple indicators of Biodesix, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Interest Income-8.8 M-9.2 M
Interest Income16.2 K25.9 K
Operating Income-37.2 M-39.1 M
Net Loss-57 M-59.9 M
Income Before Tax-46.9 M-49.3 M
Total Other Income Expense Net-9.7 M-10.2 M
Net Loss-58.9 M-61.8 M
Net Loss-46.9 M-49.3 M
Income Tax Expense6.1 M5.1 M
Change To Netincome21.8 M22.9 M
Net Loss(0.73)(0.77)
Income Quality 0.50  0.70 
Net Income Per E B T 1.11  0.89 

Biodesix Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Biodesix. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biodesix position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biodesix's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Biodesix without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Use Investing Themes to Complement your Biodesix position

In addition to having Biodesix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Biotech Thematic Idea Now

Biotech
Biotech Theme
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.